MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 206 filers reported holding MYRIAD GENETICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $325,405 | +59.5% | 14,008 | +90.0% | 0.01% | +120.0% |
Q4 2021 | $204,000 | -0.5% | 7,374 | +10.2% | 0.01% | -16.7% |
Q2 2021 | $205,000 | -93.6% | 6,689 | -92.2% | 0.01% | -95.3% |
Q2 2018 | $3,222,000 | +30.8% | 86,231 | +1.5% | 0.13% | +27.0% |
Q1 2018 | $2,464,000 | -37.7% | 84,938 | -26.2% | 0.10% | -43.8% |
Q4 2017 | $3,954,000 | +1.1% | 115,121 | +6.5% | 0.18% | -16.0% |
Q3 2017 | $3,911,000 | -2.4% | 108,092 | -30.3% | 0.21% | -36.1% |
Q2 2017 | $4,007,000 | +36.9% | 155,067 | +1.7% | 0.33% | +14.1% |
Q1 2017 | $2,927,000 | +88.2% | 152,426 | +200.0% | 0.29% | +32.9% |
Q2 2016 | $1,555,000 | -58.4% | 50,802 | -49.1% | 0.22% | -5.2% |
Q1 2016 | $3,738,000 | +77.4% | 99,882 | +104.6% | 0.23% | -13.2% |
Q4 2015 | $2,107,000 | +185.5% | 48,817 | +147.9% | 0.27% | +160.8% |
Q3 2015 | $738,000 | +29.5% | 19,689 | +17.3% | 0.10% | +34.2% |
Q2 2015 | $570,000 | +1.4% | 16,781 | +5.7% | 0.08% | -32.7% |
Q1 2015 | $562,000 | +17.6% | 15,873 | +13.0% | 0.11% | -29.8% |
Q4 2014 | $478,000 | – | 14,047 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |